Published in J Allergy Clin Immunol on December 01, 2009
Impact of delay in asthma diagnosis on health care service use. Allergy Asthma Proc (2010) 0.89
A systematic review of predictive models for asthma development in children. BMC Med Inform Decis Mak (2015) 0.80
Advances in adult asthma diagnosis and treatment in 2009. J Allergy Clin Immunol (2010) 0.77
New-onset mild asthma III: a sequel to 2 "Oscar winners". J Allergy Clin Immunol (2009) 0.75
Revisiting early intervention in adult asthma. ERJ Open Res (2015) 0.75
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med (2005) 2.26
Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol (2006) 1.68
Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest (2002) 1.46
Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol (2012) 1.40
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol (2005) 1.29
Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index. Inflamm Bowel Dis (2011) 1.18
Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. Int J Chron Obstruct Pulmon Dis (2007) 1.15
Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study. Respir Care (2007) 1.12
Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids? Pulm Pharmacol Ther (2007) 1.08
Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers. J Allergy Clin Immunol (2002) 1.07
Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Curr Med Res Opin (2006) 1.06
Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med (2009) 1.06
Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. Hum Mol Genet (2006) 1.02
Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC Pulm Med (2010) 0.95
Downstream target genes of the neuropeptide S-NPSR1 pathway. Hum Mol Genet (2006) 0.95
Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine children. Arch Dis Child (2012) 0.93
Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases. APMIS (2007) 0.93
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Ther Adv Respir Dis (2009) 0.92
Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years. Thorax (2011) 0.92
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. Respir Res (2009) 0.91
Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv (2010) 0.89
Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters. Int J Chron Obstruct Pulmon Dis (2010) 0.88
Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol (2003) 0.88
Topical tacrolimus in the treatment of atopic dermatitis--does it benefit the airways? A 4-year open follow-up. J Allergy Clin Immunol (2007) 0.87
Longitudinal follow-up of bronchial inflammation, respiratory symptoms, and pulmonary function in adolescents after repair of esophageal atresia with tracheoesophageal fistula. J Pediatr (2008) 0.86
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease. Am J Gastroenterol (2008) 0.85
Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv (2010) 0.85
Maternal smoking affects lung function and airway inflammation in young children with multiple-trigger wheeze. J Allergy Clin Immunol (2013) 0.84
Ophthalmologic findings in children with asthma receiving inhaled budesonide. J Allergy Clin Immunol (2008) 0.84
Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks. J Aerosol Med Pulm Drug Deliv (2013) 0.84
Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med (2005) 0.84
Major histocompatibility complex class II and BTNL2 associations in sarcoidosis. Eur Respir J (2013) 0.84
Sensitivity of bronchial responsiveness measurements in young infants. Chest (2006) 0.83
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. Arthritis Rheum (2006) 0.83
HLA-DRB1 allele frequencies and C4 copy number variation in Finnish sarcoidosis patients and associations with disease prognosis. Hum Immunol (2011) 0.83
Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States. Am J Gastroenterol (2002) 0.83
Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res (2010) 0.83
Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study. Inflamm Bowel Dis (2015) 0.81
Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease. Pediatr Pulmonol (2002) 0.80
Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children--not too much, not too little. Thorax (2011) 0.80
The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma. J Asthma (2008) 0.80
Challenges and opportunities in respiratory drug delivery devices. Expert Opin Drug Deliv (2010) 0.80
Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. Clin Respir J (2010) 0.80
An instrumented valved holding chamber with facemask to measure application forces and flow in young asthmatic children. J Aerosol Med Pulm Drug Deliv (2014) 0.80
Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol (2009) 0.80
Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis. Cornea (2008) 0.79
Factors associated with elevated exhaled nitric oxide fraction in infants with recurrent respiratory symptoms. Eur Respir J (2012) 0.79
A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years. J Dermatolog Treat (2010) 0.78
Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial. Curr Med Res Opin (2014) 0.78
Symptom-based classification of wheeze: how does it work in infants? J Allergy Clin Immunol (2011) 0.78
The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Eur Respir J (2012) 0.77
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Drugs R D (2013) 0.77
Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life. Am J Gastroenterol (2002) 0.77
Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. Pediatr Res (2010) 0.76
No evidence of glucocorticosteroid-induced apoptosis of airway epithelial cells In vivo. Am J Respir Crit Care Med (2002) 0.76
Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma. J Aerosol Med Pulm Drug Deliv (2014) 0.76
Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate. J Allergy Clin Immunol (2003) 0.75
Does tidal exhaled nitric oxide reflect mucosal airway inflammation in infants? Thorax (2010) 0.75
[Measuring respiratory gas exchange during orthostatic test--a novel test to diagnose tendency to hyperventilation]. Duodecim (2002) 0.75
Salmeterol and fluticasone in young children with multiple-trigger wheeze. Ann Allergy Asthma Immunol (2012) 0.75
[Why do "diet experts" deny science?]. Lakartidningen (2008) 0.75
Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. Respir Med (2011) 0.75
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen? Ther Adv Respir Dis (2011) 0.75
Tidal breathing flow measurement in awake young children by using impedance pneumography. J Appl Physiol (1985) (2013) 0.75
Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opin Drug Deliv (2015) 0.75